Atypical infections during combination therapy with anifrolumab and other immunosuppressives in patients with lupus erythematosus: A case series
Open Access
- 23 May 2025
- journal article
- case report
- Published by Wiley in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
- Vol. 23 (9) , 1164-1167
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Dangers of Herpesvirus Infection in SLE Patients Under Anifrolumab Treatment: Case Reports and Clinical ImplicationsAmerican Journal of Case Reports, 2024
- Type I interferons in host defence and inflammatory diseasesLupus Science & Medicine, 2019
- Safety, tolerability and pharmacokinetics of subcutaneous and intravenous anifrolumab in healthy volunteersLupus Science & Medicine, 2018
- Anifrolumab, an Anti–Interferon‐α Receptor Monoclonal Antibody, in Moderate‐to‐Severe Systemic Lupus ErythematosusArthritis & Rheumatology, 2017
- The Roles of Type I Interferon in Bacterial InfectionCell Host & Microbe, 2016